✦ LIBER ✦

A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer

✍ Scribed by Daniel J. Renouf; Stephen Welch; Malcolm J. Moore; Monika K. Krzyzanowska; Jennifer Knox; Ronald Feld; Geoffrey Liu; Helen MacKay; Jennifer Petronis; Lisa Wang; Eric Chen

Book ID: 113028070
Publisher: Springer
Year: 2012
Tongue: English
Weight: 294 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-1843-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of bevacizumab-based

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; François, E.; Chauffert, B.; Ichanté, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Multicenter Phase II Study of Fixed Sequ

Multicenter Phase II Study of Fixed Sequences of Capecitabine Combined with Oxaliplatin or Irinotecan in Patients with Previously Untreated Metastatic Colorectal Cancer

✍ Javier Cassinello; Jose Valero Álvarez; María José García López; Eduardo Pujol; 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 488 KB

Phase II Trial of Erlotinib and Capecita

Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer

✍ Peter Kozuch; Steve Malamud; Carrie Wasserman; Peter Homel; Takhir Mirzoyev; Mic 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

Bevacizumab plus capecitabine versus cap

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

✍ Cunningham, David; Lang, Istvan; Marcuello, Eugenio; Lorusso, Vito; Ocvirk, Janj 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 367 KB

Phase I study of dasatinib in combinatio

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

✍ Strickler, John H.; McCall, Shannon; Nixon, Andrew B.; Brady, John C.; Pang, Her 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 461 KB

3068 POSTER Capecitabine + irinotecan +

3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results

✍ S. Beslija; M. Banjin; S. Jungic; N. Obralic; G. Kecman-Malcic; I. Rakita; B. Sa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB